COMPASS Tissue
Comprehensive oncology panel (1021 genes)
CommercialActive
Key Facts
About MiRXES
RNA‑based diagnostics company delivering early‑cancer blood tests and NGS tissue profiling.
View full company profileComprehensive oncology panel (1021 genes)
RNA‑based diagnostics company delivering early‑cancer blood tests and NGS tissue profiling.
View full company profile